UBS Group AG - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 14 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$94
-98.7%
118
-99.0%
0.00%
Q4 2022$7,346
+4.9%
11,849
+88.2%
0.00%
Q3 2022$7,000
-82.1%
6,296
-44.7%
0.00%
Q4 2021$39,000
+116.7%
11,385
+188.8%
0.00%
Q2 2021$18,000
+28.6%
3,942
+32.3%
0.00%
Q1 2021$14,0002,9800.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 988,165$614,9350.54%
Quantum Private Wealth, LLC 10,000$6,2230.00%
Warberg Asset Management LLC 17,012$10,5610.00%
Belpointe Asset Management LLC 19,045$11,8520.00%
OSAIC HOLDINGS, INC. 600$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$62,7440.00%
WELLS FARGO & COMPANY/MN 59$370.00%
NORTHERN TRUST CORP 15,221$9,4720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$410.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders